The
sleep disorder narcolepsy results from loss of hypothalamic
orexin/
hypocretin neurons. Although
narcolepsy onset is usually postpubertal, current mouse models involve loss of either
orexin peptides or
orexin neurons from birth. To create a model of
orexin/
hypocretin deficiency with closer fidelity to human
narcolepsy,
diphtheria toxin A (DTA) was expressed in
orexin neurons under control of the Tet-off system. Upon
doxycycline removal from the diet of postpubertal
orexin-tTA;TetO DTA mice,
orexin neurodegeneration was rapid, with 80% cell loss within 7 d, and resulted in disrupted sleep architecture.
Cataplexy, the pathognomic symptom of
narcolepsy, occurred by 14 d when ∼5% of the
orexin neurons remained.
Cataplexy frequency increased for at least 11 weeks after
doxycycline. Temporary
doxycycline removal followed by reintroduction after several days enabled partial lesion of
orexin neurons. DTA-induced
orexin neurodegeneration caused a
body weight increase without a change in food consumption, mimicking metabolic aspects of human
narcolepsy. Because the
orexin/
hypocretin system has been implicated in the control of metabolism and addiction as well as sleep/wake regulation,
orexin-tTA; TetO DTA mice are a novel model in which to study these functions, for pharmacological studies of
cataplexy, and to study network reorganization as
orexin input is lost.